CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Clinician programmer electrode screening mode tooldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03794661
NCT03794661N/ACompleted

Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool

Abbott Medical Devices·interventional·Posted Jan 7, 2019·Updated Mar 31, 2022

In Brief

A clinical study evaluating Clinician programmer electrode screening mode tool for Essential Tremor and Parkinson's Disease. Completed, enrolled 8 participants across 3 sites.

Detailed Summary

The objective of this clinical investigation is to characterize the clinical performance of Abbott's Clinician Programmer Electrode Screening Mode tool (InformityTM tool) in programming InfinityTM deep brain stimulation (DBS) systems for patients with Parkinson's disease (PD) or essential tremor (ET).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 7, 2019
Enrollment StartJun 26, 2019
Primary CompletionDec 16, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.5 years ago

Interventions

Clinician programmer electrode screening mode tooldevice

Provides a standardized workflow to guide clinicians or trained healthcare providers through the deep brain stimulation monopolar review screening process